- Home
- ACAD vs CARG Comparison
ACAD vs CARG Comparison
Compare ACAD & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- CARG
- Stock Information
- Founded
- ACAD 1993
- CARG 2005
- Country
- ACAD United States
- CARG United States
- Employees
- ACAD N/A
- CARG N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- CARG EDP Services
- Sector
- ACAD Health Care
- CARG Technology
- Exchange
- ACAD Nasdaq
- CARG Nasdaq
- Market Cap
- ACAD 3.8B
- CARG 3.2B
- IPO Year
- ACAD 2004
- CARG 2017
- Fundamental
- Price
- ACAD $20.98
- CARG $34.18
- Analyst Decision
- ACAD Buy
- CARG Buy
- Analyst Count
- ACAD 18
- CARG 12
- Target Price
- ACAD $27.71
- CARG $37.88
- AVG Volume (30 Days)
- ACAD 2.0M
- CARG 851.0K
- Earning Date
- ACAD 08-05-2025
- CARG 08-07-2025
- Dividend Yield
- ACAD N/A
- CARG N/A
- EPS Growth
- ACAD N/A
- CARG 27.38
- EPS
- ACAD 1.37
- CARG 0.36
- Revenue
- ACAD $996,283,000.00
- CARG $903,746,000.00
- Revenue This Year
- ACAD $13.39
- CARG $7.60
- Revenue Next Year
- ACAD $10.59
- CARG $8.07
- P/E Ratio
- ACAD $15.33
- CARG $95.86
- Revenue Growth
- ACAD 22.42
- CARG 0.63
- 52 Week Low
- ACAD $13.40
- CARG $21.65
- 52 Week High
- ACAD $25.23
- CARG $41.33
- Technical
- Relative Strength Index (RSI)
- ACAD 45.70
- CARG 60.86
- Support Level
- ACAD $20.75
- CARG $32.95
- Resistance Level
- ACAD $23.09
- CARG $35.38
- Average True Range (ATR)
- ACAD 0.78
- CARG 0.83
- MACD
- ACAD -0.20
- CARG 0.09
- Stochastic Oscillator
- ACAD 9.83
- CARG 67.31
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.
About CARG CarGurus Inc.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.